Register now and save up to 30% on your registration fees. Book your hotel reservation early through the ENDO Housing Block for best price and location.

Bi-weekly newsletter with health and science policy actions and updates. In this issue:

- Society, CDC Host T Assays Conference
- Long-Term Fix for Physician Payment Cuts Still Unclear
- NIH and FDA Announce Partnership

Endocrine Society Responds to Senate Finance Committee Report on Avandia

The Endocrine Society urges the FDA to formally reconsider the concerns about the safety of the drug rosiglitazone (Avandia) by re-convening the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) to reassess the drug's safety.

Read the full Society statement...